Literature DB >> 22909197

Genome-wide approaches in pharmacogenomics: heritability estimation and pharmacoethnicity as primary challenges.

Eric R Gamazon, Minoli Perera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22909197      PMCID： PMC3710727          DOI： 10.2217/pgs.12.88

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  32 in total

1.  Natural variation in human gene expression assessed in lymphoblastoid cells.

Authors:  Vivian G Cheung; Laura K Conlin; Teresa M Weber; Melissa Arcaro; Kuang-Yu Jen; Michael Morley; Richard S Spielman
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

2.  Genetic research and health disparities.

Authors:  Pamela Sankar; Mildred K Cho; Celeste M Condit; Linda M Hunt; Barbara Koenig; Patricia Marshall; Sandra Soo-Jin Lee; Paul Spicer
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

Review 3.  Cellular genomics for complex traits.

Authors:  Emmanouil T Dermitzakis
Journal:  Nat Rev Genet       Date:  2012-02-14       Impact factor: 53.242

4.  Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

Authors:  Mark J Rieder; Alexander P Reiner; Brian F Gage; Deborah A Nickerson; Charles S Eby; Howard L McLeod; David K Blough; Kenneth E Thummel; David L Veenstra; Allan E Rettie
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

5.  Changing the paradigm from 'race' to human genome variation.

Authors:  Charmaine D M Royal; Georgia M Dunston
Journal:  Nat Genet       Date:  2004-11       Impact factor: 38.330

6.  Population genomics of human gene expression.

Authors:  Barbara E Stranger; Alexandra C Nica; Matthew S Forrest; Antigone Dimas; Christine P Bird; Claude Beazley; Catherine E Ingle; Mark Dunning; Paul Flicek; Daphne Koller; Stephen Montgomery; Simon Tavaré; Panos Deloukas; Emmanouil T Dermitzakis
Journal:  Nat Genet       Date:  2007-09-16       Impact factor: 38.330

7.  Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.

Authors:  Federico Innocenti; Samir D Undevia; Lalitha Iyer; Pei Xian Chen; Soma Das; Masha Kocherginsky; Theodore Karrison; Linda Janisch; Jacqueline Ramírez; Charles M Rudin; Everett E Vokes; Mark J Ratain
Journal:  J Clin Oncol       Date:  2004-03-08       Impact factor: 44.544

8.  Genome-wide discovery of loci influencing chemotherapy cytotoxicity.

Authors:  James W Watters; Aldi Kraja; Melissa A Meucci; Michael A Province; Howard L McLeod
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-28       Impact factor: 11.205

9.  Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.

Authors:  R Stephanie Huang; Shiwei Duan; Sunita J Shukla; Emily O Kistner; Tyson A Clark; Tina X Chen; Anthony C Schweitzer; John E Blume; M Eileen Dolan
Journal:  Am J Hum Genet       Date:  2007-08-01       Impact factor: 11.025

10.  Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs.

Authors:  S Hong Lee; Teresa R DeCandia; Stephan Ripke; Jian Yang; Patrick F Sullivan; Michael E Goddard; Matthew C Keller; Peter M Visscher; Naomi R Wray
Journal:  Nat Genet       Date:  2012-02-19       Impact factor: 38.330
View more
  6 in total

1.  Unravelling the transcriptomic landscape of the major phase II UDP-glucuronosyltransferase drug metabolizing pathway using targeted RNA sequencing.

Authors:  A Tourancheau; G Margaillan; M Rouleau; I Gilbert; L Villeneuve; E Lévesque; A Droit; C Guillemette
Journal:  Pharmacogenomics J       Date:  2015-04-14       Impact factor: 3.550

2.  Leveraging a High-Throughput Screening Method to Identify Mechanisms of Individual Susceptibility Differences in a Genetically Diverse Zebrafish Model.

Authors:  Dylan J Wallis; Jane La Du; Preethi Thunga; Daniel Elson; Lisa Truong; Siva K Kolluri; Robyn L Tanguay; David M Reif
Journal:  Front Toxicol       Date:  2022-04-29

3.  Evidence of selection on splicing-associated loci in human populations and relevance to disease loci mapping.

Authors:  Eric R Gamazon; Anuar Konkashbaev; Eske M Derks; Nancy J Cox; Younghee Lee
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

4.  Genetic diversity of 'Very Important Pharmacogenes' in two South-Asian populations.

Authors:  Neeraj Bharti; Ruma Banerjee; Archana Achalere; Sunitha Manjari Kasibhatla; Rajendra Joshi
Journal:  PeerJ       Date:  2021-11-10       Impact factor: 2.984

5.  Genetics of adverse reactions to haloperidol in a mouse diallel: a drug-placebo experiment and Bayesian causal analysis.

Authors:  James J Crowley; Yunjung Kim; Alan B Lenarcic; Corey R Quackenbush; Cordelia J Barrick; Daniel E Adkins; Ginger S Shaw; Darla R Miller; Fernando Pardo-Manuel de Villena; Patrick F Sullivan; William Valdar
Journal:  Genetics       Date:  2013-11-15       Impact factor: 4.562

6.  Translating pharmacogenomics discoveries into the clinic: an implementation framework.

Authors:  R Stephanie Huang; Eric R Gamazon
Journal:  Genome Med       Date:  2013-10-18       Impact factor: 11.117
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.